CPRX
Price:
$21.62
Market Cap:
$2.58B
Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthenic syndrome (LEMS); and Ruzurgi for the treatment of pediatric LEMS patients. The company also develops Firdapse for the treatment of MuSK antibody positive myasthenia gravis, and spinal muscular atrophy type 3, as well as to treat hereditary neuropathy with liability to pressure palsies. It has license agreements with BioMarin Pharmaceutical Inc.; a...[Read more]
Industry
Biotechnology
IPO Date
2006-11-08
Stock Exchange
NASDAQ
Ticker
CPRX
According to Catalyst Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current Dividend Yield is 0%. This represents a change of 0% compared to the average of 0% of the last 4 quarters.
The mean historical Dividend Yield of Catalyst Pharmaceuticals, Inc. over the last ten years is 0%. The current 0% Dividend Yield has changed 0% with respect to the historical average. Over the past ten years (40 quarters), CPRX's Dividend Yield was at its highest in in the December 2014 quarter at 0%. The Dividend Yield was at its lowest in in the December 2014 quarter at 0%.
Average
0%
Median
0%
Minimum
0%
Maximum
0%
Discovering the peaks and valleys of Catalyst Pharmaceuticals, Inc. Dividend Yield, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 0%
Maximum Annual Dividend Yield = 0%
Minimum Annual Increase = 0%
Minimum Annual Dividend Yield = 0%
Year | Dividend Yield | Change |
---|---|---|
2023 | 0% | 0% |
2022 | 0% | 0% |
2021 | 0% | 0% |
2020 | 0% | 0% |
2019 | 0% | 0% |
2018 | 0% | 0% |
2017 | 0% | 0% |
2016 | 0% | 0% |
2015 | 0% | 0% |
2014 | 0% | 0% |
The current Dividend Yield of Catalyst Pharmaceuticals, Inc. (CPRX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
0%
5-year avg
0%
10-year avg
0%
Catalyst Pharmaceuticals, Inc.’s Dividend Yield is less than Day One Biopharmaceuticals, Inc. (0%), less than Terns Pharmaceuticals, Inc. (0%), less than X4 Pharmaceuticals, Inc. (0%), less than Inozyme Pharma, Inc. (0%), less than Mereo BioPharma Group plc (0%), less than Exelixis, Inc. (0%), less than TG Therapeutics, Inc. (0%), less than Viking Therapeutics, Inc. (0%), less than Madrigal Pharmaceuticals, Inc. (0%), less than BioXcel Therapeutics, Inc. (0%), less than Axsome Therapeutics, Inc. (0%), less than Incyte Corporation (0%), less than ImmunoGen, Inc. (0%), less than Sarepta Therapeutics, Inc. (0%), less than ACADIA Pharmaceuticals Inc. (0%), less than Intercept Pharmaceuticals, Inc. (0%), less than Hepion Pharmaceuticals, Inc. (0%), less than Akero Therapeutics, Inc. (0%), less than Reata Pharmaceuticals, Inc. (0%),
Company | Dividend Yield | Market cap |
---|---|---|
0% | $1.28B | |
0% | $492.65M | |
0% | $98.92M | |
0% | $188.22M | |
0% | $589.54M | |
0% | $9.66B | |
0% | $5.01B | |
0% | $4.72B | |
0% | $6.80B | |
0% | $17.42M | |
0% | $4.22B | |
0% | $13.47B | |
0% | $8.73B | |
0% | $11.64B | |
0% | $2.84B | |
0% | $794.69M | |
0% | $3.48M | |
0% | $1.99B | |
0% | $6.57B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Catalyst Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Catalyst Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Dividend Yield?
How can you use the Dividend Yield?
What is Catalyst Pharmaceuticals, Inc.'s Dividend Yield?
How is the Dividend Yield calculated for Catalyst Pharmaceuticals, Inc. (CPRX)?
What is the highest Dividend Yield for Catalyst Pharmaceuticals, Inc. (CPRX)?
What is the 3-year average Dividend Yield for Catalyst Pharmaceuticals, Inc. (CPRX)?
What is the 5-year average Dividend Yield for Catalyst Pharmaceuticals, Inc. (CPRX)?
How does the current Dividend Yield for Catalyst Pharmaceuticals, Inc. (CPRX) compare to its historical average?